Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides: I. Correlation of graft survival with antidonor IgG antibody subclasses

Transplantation

Volumn 64, Issue 12, 1997, Pages 1665-1670

  Mhoyan, Anna ^a   Cramer, Donald V ^b   Baquerizo, Angeles ^b   Shirwan, Haval ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ALLOGRAFT; ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS TRANSPLANTATION;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; ISOANTIBODIES; PEPTIDES; RATS; RATS, INBRED STRAINS; THYMUS GLAND; TISSUE DONORS;

EID: 0031450005     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00006     Document Type: Conference Paper

References (36)

1. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
2. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
3. + T cell and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
4. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
5. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177.
6. bm3 molecule. J Immunol 1995; 155: 2419.
7. Braun MY, McCormack A, Webb G, Batchelor JR. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Transplant Proc 1993; 25: 863.
8. Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: an overview. Transplant Immunol 1993; 1: 3.
9. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection: an undefined conundrum. Transplantation 1993; 52: 389.
10. + T cell-dependent antibody-mediated graft rejection. Immunol Today 1992; 13: 434.
11. Shirwan H, Mhoyan A, Learner M, Wang C, Cramer DV. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance. Transplant Proc 1997; 29: 1134.
12. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993; 56: 461.
13. Chowdhury NC, Murphy B, Sayegh MH, et al. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation 1996; 62: 1878.
14. Sayegh MH, Perico N, Gallon L, et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125.
15. Odorico JS, Posselt AM, Naji A, Markmann JF, Barker CF. Promotion of rat cardiac allograft survival by intrathymic inoculation of donor splenocytes. Transplantation 1993; 55: 1104.
16. Ohzato H, Monaco AP. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992; 54: 1090.
17. Markmann JF, Bassiri H, Desai NM, Kim JI, Odorico JS, Barker CF. Donor antigen-specific T lymphocyte deletion after intrathymic inoculation. Transplant Proc 1993; 25: 305.
18. Binder J, Graser E, Hancock WW, et al. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 1995; 60: 1516.
19. Gracie JA, Bolton EM, Porteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172: 1547.
20. Pober JS, Orosz CG, Rose ML, Savage COS. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343.
21. Shirwan H, Ohanjanian M, Burcham G, Makowka L, Cramer DV. Structure and diversity of rat T cell receptor alpha-chain genes. J Immunol 1993; 150: 2295.
22. Borie DC, Cramer DV, Shirwan H, et al. Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes. Transplantation 1995; 60: 1504.
23. Wasowska B, Wieder KJ, Hancock WW, et al. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin. J Immunol 1996; 156: 395.
24. Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J Immunol 1994; 153: 3307.
25. Heath WR, Sherman LA. Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur J Immunol 1991; 21: 153.
26. Bluestone JA, Kaliyaperumal A, Jameson S, Miller S, Dick R II. Peptide-induced changes in class I heavy chains alter allorecognition. J Immunol 1993; 151: 3943.
27. Benham AM, Sawyer GJ, Fabre JW. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation 1995; 59: 1028.
28. Oluwole SF, Jin MX, Chowdhury NC, Ohajekwe OA. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Transplantation 1994; 58: 1077.
29. Shimomura K, Hardy MA, Oluwole SF. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Transplantation 1995; 60: 806.
30. Hoffman MW, Ruschmeyer D, Pichlmayr R. Mechanisms of tolerance induction by intrathymic injection of allogeneic cells. Transplant Proc 1995; 27: 130.
31. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
32. Vidard L, Colarusso LJ, Benacerraf B. Specific T-cell tolerance may reflect selective activation of lymphokine synthesis. Proc Natl Acad Sci USA 1995; 92: 2259.
33. Khoury SJ, Akalin E, Chandraker A, et al. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 1995; 155: 4521.
34. Chen N, Gao Q, Field EH. Prevention of Th1 responses is critical for tolerance. Transplantation 1996; 61: 1076.
35. Binder J, Hancock WW, Watschinger B, Wasowska B, Sayegh MH, Kupiec-Weglinski JW. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts. Transplantation 1995; 59: 590.
36. Shirwan H, Wu GD, Barwari L, Liu A, Cramer DV. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism. Transplantation 1997; 64: 1671.